The naloxone component in Targinact tablets is intended to counteract opioid-induced constipation. Trials conducted with Targinact in patients with moderate to severe non-cancer pain have shown no difference in pain control against oxycodone. Targinact tablets reduced but did not eliminate the need for laxatives.